Validating the deuterium dilution method to measure body composition of common eider

2016 ◽  
Vol 40 (3) ◽  
pp. 456-463 ◽  
Author(s):  
Joshua M. Beuth ◽  
Peter W. C. Paton ◽  
Jason E. Osenkowski ◽  
Scott R. McWilliams
2016 ◽  
Vol 40 (3) ◽  
pp. 464-469 ◽  
Author(s):  
Joshua M. Beuth ◽  
Peter W. C. Paton ◽  
Jason E. Osenkowski ◽  
Scott R. McWilliams

2019 ◽  
Vol 149 (5) ◽  
pp. 847-855 ◽  
Author(s):  
Sika M Kumordzie ◽  
Seth Adu-Afarwuah ◽  
Mary Arimond ◽  
Rebecca R Young ◽  
Theodosia Adom ◽  
...  

ABSTRACT Background Few studies have evaluated the long-term effects of nutritional supplementation during the first 1000 d of life. We previously reported that maternal and child lipid-based nutrient supplements (LNS) increased child length by 18 mo. Objective The aim of this study was to examine the effects of LNS on later growth and body composition at 4–6 y of age. Design This was a follow-up of children in the International Lipid-based Nutrient Supplements (iLiNS)-DYAD trial in Ghana. Women (n = 1320) at ≤20 weeks of gestation were randomly assigned to: 1) iron and folic acid during pregnancy and 200 mg calcium/d for 6 mo postpartum, 2) multiple micronutrients (1–2 RDA of 18 vitamins and minerals) during both periods, or 3) maternal LNS during both periods plus child LNS from 6 to 18 mo. At 4–6 y, we compared height, height-for-age z score (HAZ), and % body fat (deuterium dilution method) between the LNS group and the 2 non-LNS groups combined. Results Data were available for 961 children (76.5% of live births). There were no significant differences between LNS compared with non-LNS groups in height [106.7 compared with 106.3 cm (mean difference, MD, 0.36; P = 0.226)], HAZ [−0.49 compared with −0.57 (MD = 0.08; P = 0.226)], stunting (< -2 SD) [6.5 compared with 6.3% (OR = 1.00; P = 0.993)], or % body fat [15.5 compared with 15.3% (MD = 0.16; P = 0.630)]. However, there was an interaction with maternal prepregnancy BMI (kg/m2) (P-interaction = 0.046 before correction for multiple testing): among children of women with BMI < 25 , LNS children were taller than non-LNS children (+1.1 cm, P = 0.017), whereas there was no difference among children of women with BMI ≥ 25 (+0.1 cm; P = 0.874). Conclusions There was no overall effect of LNS on height at 4–6 y in this cohort, which had a low stunting rate, but height was greater in the LNS group among children of nonoverweight/obese women. There was no adverse impact of LNS on body composition. This trial was registered at clinicaltrials.gov as NCT00970866.


2013 ◽  
Vol 143 (5) ◽  
pp. 735-741 ◽  
Author(s):  
George PrayGod ◽  
Nyagosya Range ◽  
Daniel Faurholt-Jepsen ◽  
Kidola Jeremiah ◽  
Maria Faurholt-Jepsen ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Christian Fabiansen ◽  
Bernardette Cichon ◽  
Charles W. Yaméogo ◽  
Ann-Sophie Iuel-Brockdorf ◽  
Kevin P. Q. Phelan ◽  
...  

Abstract Children with moderate acute malnutrition (MAM) are treated based on low weight-for-length z-score (WLZ), low mid-upper arm circumference (MUAC) or both. This study aimed to assess associations of admission criteria and body composition (BC), to improve treatment of MAM. We undertook a cross-sectional study among 6–23 months old Burkinabe children with MAM. Fat-free (FFM) and fat mass (FM) were determined by deuterium dilution and expressed as FFM (FFMI) and FM index (FMI). Of 1,489 children, 439 (29.5%) were recruited by low MUAC only (MUAC-O), 734 (49.3%) by low WLZ and low MUAC (WLZ-MUAC) and 316 (21.2%) by low WLZ only (WLZ-O). Thus, 1,173 (78.8%) were recruited by low MUAC, with or without low WLZ (ALL-MUAC). After adjustments, WLZ-O had 89 g (95% confidence interval (CI) 5; 172) lower FFM compared to MUAC-O. Similarly, WLZ-O had 0.89 kg/m2 (95% CI 0.77; 1.01) lower FFMI compared to MUAC-O, whereas there was no difference for FMI. However, boys included by WLZ-O compared to MUAC-O had 0.21 kg/m2 (95% CI 0.05; 0.38) higher FMI. In contrast, girls included by WLZ-O had 0.17 (95% CI 0.01; 0.33) kg/m2 lower FMI compared to MUAC-O (interaction, p = 0.002). We found that different criteria for admission into MAM treatment programmes select children with differences in BC, especially FFMI. Trial registration: ISRCTN42569496.


Sign in / Sign up

Export Citation Format

Share Document